Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex

Brain and Development

Volumn 34, Issue 6, 2012, Pages 478-486

  Mori, Kenji ^a   Mori, Tatsuo ^a   Toda, Yoshihiro ^a   Fujii, Emiko ^a   Miyazaki, Masahito ^a   Harada, Masafumi ^a   Kagami, Shoji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

GABA; Glutamate; Iomazenil SPECT; Proton MRS; Tuberous sclerosis

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR; GLUTAMIC ACID; INOSITOL; IOMAZENIL I 123; N ACETYLASPARTIC ACID;

ARTICLE; BRAIN CORTEX; CASE REPORT; CHILD; CONTROLLED STUDY; CORTICAL TUBER; EPILEPTOGENESIS; FEMALE; HUMAN; MALE; PARIETAL LOBE; POINT RESOLVED SPECTROSCOPY; PRESCHOOL CHILD; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTROSCOPY; TEMPORAL LOBE; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX;

ASPARTIC ACID; BRAIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FLUMAZENIL; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; INOSITOL; IODINE RADIOISOTOPES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; RADIOPHARMACEUTICALS; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUBEROUS SCLEROSIS;

EID: 84861200515     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.09.001     Document Type: Article

References (28)

1. Roach E.S., Gomez M.R., Northrup H. Tuberous sclerosis complex consensus conference. Revised clinical diagnostic criteria. J Child Neurol 1998, 13:624-628.
2. Jansen F.E., Braun K.P., van Nieuwenhuizen O., Huiskamp G., Vincken K.L., van Huffelen A.C., et al. Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis. Arch Neurol 2003, 60:1580-1584.
3. Kagawa K., Chugani D.C., Asano E., Juhász C., Muzik O., Shah A., et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-l-tryptophan positron emission tomography (PET). J Child Neurol 2005, 20:429-438.
4. Wu J.Y., Salamon N., Kirsch H.E., Mantle M.M., Nagarajan S.S., Kurelowech L., et al. Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex. Neurology 2010, 74:392-398.
5. Curatolo P., Verdecchia M., Bombardieri R. Vigabatrin for tuberous sclerosis complex. Brain Dev 2001, 23:649-653.
6. Harada M., Taki M.M., Nose A., Kubo H., Mori K., Nishitani H., et al. Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. J Autism Dev Disord 2011, 41:447-454.
7. Mescher M., Merkle H., Kirsh J., Garwood M., Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998, 11:266-272.
8. Morimoto K., Tamagami H., Matsuda K. Central-type benzodiazepine receptors and epileptogenesis: basic mechanisms and clinical validity. Epilepsia 2005, 46(suppl 5):184-188.
9. Kaneko K., Sasaki M., Morioka T., Koga H., Abe K., Sawamoto H., et al. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET. Nucl Med Commun 2006, 27:893-899.
10. Barkovich A.J., Kuzniecky R.I., Dobyns W.B., Jackson G.D., Becker L.E., Evrard P. A classification scheme for malformations of cortical development. Neuropediatrics 1996, 27:59-63.
11. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-15.
12. van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997, 277:805-808.
13. Griffiths P.D., Bolton P., Verity C. White matter abnormalities in tuberous sclerosis complex. Acta Radiol 1998, 39:482-486.
14. Mizuno S., Takahashi Y., Kato Z., Goto H., Kondo N., Hoshi H. Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis. Acta Neurol Scand 2000, 102:175-178.
15. Mukonoweshuro W., Wilkinson I.D., Griffiths P.D. Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex. Am J Neuroradiol 2001, 22:1920-1925.
16. Yapici Z., Dincer A., Eraksoy M. Proton spectroscopic findings in children with epilepsy owing to tuberous sclerosis complex. J Child Neurol 2005, 20:517-522.
17. Matthews P.M., Andermann F., Arnold D.L. A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology 1990, 40:985-989.
18. Kälviäinen R., Halonen T., Pitkänen A., Reikkinen P.J. Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies. J Neurochem 1993, 60:1244-1250.
19. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993, 341:1607-1610.
20. Petroff O.A., Pleban L.A., Spencer D.D. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995, 13:1197-1211.
21. Morimoto K., Fahnestock M., Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 2004, 73:1-60.
22. Simister R.J., McLean M.A., Barker G.J., Duncan J.S. Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy. Epilepsy Res 2007, 74:107-115.
23. Aasly J., Silfvenius H., Aas T.C., Sonnewald U., Olivecrona M., Juul R., et al. Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Res 1999, 35:211-217.
24. Valencia I., Legido A., Yelin K., Khurana D., Kothare S.V., Katsetos C.D. Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex. J Child Neurol 2006, 21:1058-1063.
25. Fujita M., Hashikawa K., Nagai T., Kodaka R., Uehara T., Nishimura T. Decrease of the central type benzodiazepine receptor in cortical tubers in a patient with tuberous sclerosis. Clin Nucl Med 1997, 22:130-131.
26. White R., Hua Y., Scheithauer B., Lynch D.R., Henske E.P., Crino P.B. Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 2001, 49:67-78.
27. Ben-Ari Y. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci 2002, 3:728-739.
28. --cotransporter, in epilepsy-associated malformations of cortical development. Neuroscience 2007, 145:185-196.